Familial Partial Lipodystrophy
Oncology·MeSH: Lipodystrophy, Familial Partial
Prevalence
0.5 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Waylivra | PTC THERAPEUTICS, INC. (PTCT) |
Frequently asked questions
How many drugs are in development for Familial Partial Lipodystrophy?
BioSniper tracks 1 drug in development for Familial Partial Lipodystrophy across 1 company.
How many clinical trials target Familial Partial Lipodystrophy?
There are 3 clinical trials targeting Familial Partial Lipodystrophy tracked by BioSniper.
What is the prevalence of Familial Partial Lipodystrophy?
The estimated prevalence of Familial Partial Lipodystrophy is approximately 0.5 per 100,000 population.
Deep-dive into Familial Partial Lipodystrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis